Telemedicine in French Memory Clinics During the COVID-19 Pandemic - Université de Picardie Jules Verne Accéder directement au contenu
Article Dans Une Revue Journal of Alzheimer's Disease Année : 2022

Telemedicine in French Memory Clinics During the COVID-19 Pandemic

Julien Lagarde
  • Fonction : Auteur
  • PersonId : 755946
  • IdRef : 130610062
David Maltete
  • Fonction : Auteur

Résumé

This multicenter study was conducted in French memory clinics during the first COVID-2019 lockdown (March-May 2020). The objective was to evaluate the effect of a telemedicine consultation on treatment modification in dementia care. Among 874 patients who had a telemedicine consultation, 103 (10.7%) had treatment modifications, in particular those living with a relative or diagnosed with Alzheimer's disease. A control group of patients referred March-May 2019 was also included. Treatment modification rate was similar between periods with an adjusted percentage difference of -4% (p = 0.27). Telemedicine consultations allowed treatment modifications with only a minor short-term negative impact on therapeutic strategies.

Dates et versions

hal-03647957 , version 1 (21-04-2022)

Identifiants

Citer

Alexandre Morin, Thibaut Pressat-Laffouilhere, Marie Sarazin, Julien Lagarde, Carole Roue-Jagot, et al.. Telemedicine in French Memory Clinics During the COVID-19 Pandemic. Journal of Alzheimer's Disease, 2022, 86 (2), pp.525-530. ⟨10.3233/JAD-215459⟩. ⟨hal-03647957⟩
66 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More